XXII Projected Dividend Yield

22nd Century Group Inc ( NASDAQ : XXII )

22nd Century Group is a agricultural biotechnology and intellectual property company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. In tobacco, hemp/cannabis, and hop plants, Co. uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and agronomic traits. Co. has developed proprietary bright and burley Very Low Nicotine Content tobaccos. Co. has developed its SPECTRUM® research cigarettes.

20 YEAR PERFORMANCE RESULTS